Gapping up on strong earnings/guidance:

VOXW +74.4% (very light volume), HRSH +21.1%, PTIE +11.8%, NT +11.1% (also names interim CFO), BWLD +9.5% (also upgraded to Outperform at Morgan Keegan), CTB +8.6%, ININ +8.2% (also upgraded to Outperform at Morgan Keegan), CBG +8.0%, OSCI +8.0% (also FDA approves Factive tablets for 5-day treatment of community-acquired pneumonia), UNTD +7.3%, MA +7.2%, BGC +6.9% (very light volume), IVGN +6.3% (also tgt raised to $75 at ThinkEquity), POZN +5.9% (very light volume), VPHM +5.7%, CMG +5.5% (also upgraded to Outperform at Morgan Keegan)... Other news: BCRX +9.4% (confirms yesterday's news (10:31) that St. Jude study shows effectiveness of Peramivir in prevention of mortality in mouse model of avian influenza H5N1), ADLS +7.4%